Mutant zebrafish lacking slc25a22a show spontaneous seizures and respond to the anti-seizure medication valproic acid

Mutant zebrafish lacking slc25a22a show spontaneous seizures and respond to the anti-seizure medication valproic acid

Saved in:

Bibliographic Details
Main Authors:	So-Hyun Lee, Ting Liang, Gopalakrishnan Chandrasekaran, Jun Zhang, Seong Soon Kim, Sundareswaran Varier Parvathi, Seok Won Lee, Eun-Seo Cho, Hee-Young Shin, Young-Gyu Yoon, Jihoon Jo, Myung Ae Bae, Seok-Yong Choi, Myeong-Kyu Kim
Format:	Article
Language:	English
Published:	The Company of Biologists 2025-06-01
Series:	Disease Models & Mechanisms
Subjects:	epilepsy slc25a22a anti-seizure medications glutamate carrier mitochondria
Online Access:	http://dmm.biologists.org/content/18/6/dmm052275
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epilepsy of Infancy With Migrating Focal Seizures
by: Samuel Kamoroff, et al.
Published: (2025-06-01)

Clinical and genetic analysis of epilepsy with myoclonic-atonic seizures caused by SLC6A1 gene variant
by: Zhen Li, et al.
Published: (2025-01-01)

The role of glutamine synthetase expression and cystine/glutamate transporter (SLC7A11, xCT) in epilepsy pathogenesis of patients with supratentorial brain gliomas
by: M. Yu. Prokudin, et al.
Published: (2022-07-01)

Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma
by: Yan Liao, et al.
Published: (2025-01-01)

Lack of significant ganglioside changes in Slc17a5 heterozygous mice: Relevance to FSASD and Parkinson's disease
by: Marya S. Sabir, et al.
Published: (2025-06-01)

N-phenylmaleimide induces bioenergetic switch and suppresses tumor growth in glioblastoma tumorspheres by inhibiting SLC25A11
by: Hye Joung Cho, et al.
Published: (2025-05-01)

Ginsenosides as Potential Natural Ligands of SLC3A2: Computational Insights in Cancer
by: Jing Lu
Published: (2025-06-01)

Polycythemia and Systemic Manifestations in a 19-year-old Female with SLC30A10 Mutation
by: Adel Fahad Almarzouki, et al.
Published: (2025-01-01)

Lack of the human choline transporter‐like protein SLC44A2 causes hearing impairment and a rare red blood phenotype
by: Bérengère Koehl, et al.
Published: (2023-01-01)

SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function
by: Mihyun Bae, et al.
Published: (2021-01-01)

Glutamate transporter SLC1A6 promotes resistance to immunotherapy in cancer
by: Chenchen Li, et al.
Published: (2025-06-01)

Lack of association between VNTR polymorphism of dopamine transporter gene (SLC6A3) and schizophrenia in a Brazilian sample Ausência de associação entre o polimorfismo VNTR do gene do transportador de dopamina (SLC6A3) e esquizofrenia em uma população brasileira
by: Quirino Cordeiro, et al.
Published: (2004-12-01)

Editorial: SLC12A5-dependent neurological disorders
by: Igor Medina, et al.
Published: (2025-05-01)

The ammonia-Slc4a11 axis in T cells alleviates LPS-induced mastitis
by: Yuqing Wu, et al.
Published: (2025-04-01)

Clinicopathological characteristics of invasive stratified mucinous carcinoma of the cervix and the expression and clinical significance of SLC7A11, SLC3A2 and PD-L1
by: Changyu Lu, et al.
Published: (2024-12-01)

Sputum SLC40A1 as a Novel Biomarker is Increased in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Ju X, et al.
Published: (2025-04-01)

Blocking SLC7A11 attenuates the proliferation of esophageal squamous cell carcinoma cells
by: Wen-Ting Li, et al.
Published: (2024-12-01)

Predictive role of SLC1A5 in neuroblastoma prognosis and immunotherapy
by: Jian Cheng, et al.
Published: (2025-01-01)

The NF-κB-SLC7A11 axis regulates ferroptosis sensitivity in inflammatory macrophages
by: Mengjie Yang, et al.
Published: (2025-08-01)

ATF4 promotes glutaminolysis and glycolysis in colorectal cancer by transcriptionally inducing SLC1A5
by: Zhou Zengli, et al.
Published: (2024-12-01)

Mechanism of intestinal flora affecting SLC2A9 transport function to promote the formation of hyperuricemia
by: Ying Ying, et al.
Published: (2024-12-01)

Icariside II induces ferroptosis through the down-regulation of SLC7A11 in ovarian cancer
by: Donglan Yuan, et al.
Published: (2025-04-01)

Decreased Expression of the EAAT5 Glutamate Transporter at Photoreceptor Synapses in Early, Pre-Clinical Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis
by: Ali El Samad, et al.
Published: (2024-11-01)

Investigation of the cytotoxic effects and mechanisms of the SLC39A6-targeting ADC drug BRY812 in CRC
by: Xianglin Liu, et al.
Published: (2025-05-01)

SLC25A19 drives colorectal cancer progression by regulating p53
by: Jinbo Jiang, et al.
Published: (2024-09-01)

YTHDF2 regulates the adriamycin (ADM) resistance in NKTCL by modulating the m6A modification of SLC16A9
by: Meng Dong, et al.
Published: (2025-09-01)

Generation of a new Slc20a2 knockout mouse line as in vivo model for primary brain calcification
by: Hisaka Kurita, et al.
Published: (2025-08-01)

Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells
by: Haoying Yang, et al.
Published: (2024-11-01)

Targeting p62 by sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment
by: Qiuming Zou, et al.
Published: (2025-02-01)

Roles of Single Nucleotide Polymorphisms in the SLC6A2 Gene in the Risk of Vasovagal Syncope Among Children in Eastern China: A Case‐Control Study
by: Minmin Wang, et al.
Published: (2025-03-01)

Evaluation of SLC6A8 species conservation and the effect of pathogenic variants on creatine transport
by: Taryn Diep, et al.
Published: (2025-10-01)

SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer
by: Lutfi H. Alfarsi, et al.
Published: (2025-01-01)

SLC26A4 C.317C > A Variant: Functional Analysis and Patient‐Derived Induced Pluripotent Stem Line Development
by: Yijing Li, et al.
Published: (2025-04-01)

SLC10A3 regulates ferroptosis of glioblastoma through the STAT3/GPX4 pathway
by: Qian Sun, et al.
Published: (2025-07-01)

SLC25A46 is required for mitochondrial lipid homeostasis and cristae maintenance and is responsible for Leigh syndrome
by: Alexandre Janer, et al.
Published: (2016-07-01)

Identification and validation of LDHA and SLC16A1 for predicting prognosis and diagnosis in lower-grade glioma
by: Jingyi Huang, et al.
Published: (2025-08-01)

SLC1A3 is a novel prognostic biomarker associated with immunity and EMT in hepatocellular carcinoma
by: Renhou Zhi, et al.
Published: (2024-11-01)

Integrating transcriptomic and metabolomic analyses to characterize the potential function of SLC1A5 in thyroid cancer
by: Fengling Shan, et al.
Published: (2025-05-01)

SLC7A11-mediated cell death mechanism in cancer: a comparative study of disulfidptosis and ferroptosis
by: Wen-Wen Zhu, et al.
Published: (2025-06-01)

Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarker
by: Ping Yang, et al.
Published: (2025-04-01)